Bristol-Myers Squibb (BMY) Tops Q2 EPS by 13c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $66.97 -0.06%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
XYF, SQZB, RENO, More
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
XYF, SQZB, RENO, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.93, $0.13 better than the analyst estimate of $1.80. Revenue for the quarter came in at $11.89 billion versus the consensus estimate of $11.44 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2022 EPS of $7.44-$7.74, versus the consensus of $7.46. Bristol-Myers Squibb sees FY2022 revenue of $46 billion, versus the consensus of $46.24 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
- Freedom Broker Starts Citizens Inc. (CIA) at Buy
- UBS Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
